Cerevel Therapeutics
CERE
#1960
Rank
ยฃ6.35 B
Marketcap
ยฃ34.89
Share price
0.00%
Change (1 day)
107.12%
Change (1 year)

Cerevel Therapeutics (CERE) - Cash on Hand

Cash on Hand as of March 2024 : ยฃ0.65 Billion

According to Cerevel Therapeutics's latest financial reports the company has ยฃ0.65 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Cerevel Therapeutics - Cash on Hand chart (from 2020 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31ยฃ0.77 B5.49%
2022-12-31ยฃ0.73 B75.94%
2021-12-31ยฃ0.41 B48.9%
2020-12-31ยฃ0.28 B363.92%
2019-12-31ยฃ60.66 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
ยฃ0.66 B 1.27%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.69 B 158.66%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.43 B 118.60%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.62 B-4.52%๐Ÿ‡บ๐Ÿ‡ธ USA